Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001641172-25-015207

CEO & President bought 107 shares at $7.70 ($824)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Equels Thomas K CEO & President 2025-06-13 Purchase +107 $7.70 $824 38,885 D: show line 1 in the form
Open-market purchases · 107 sh · avg $7.70 · $824
Loading xslF345X05/ownership.xml…